Anticonvulsant and sleep-waking influences of riluzole in a rat model of absence epilepsy

Eur J Pharmacol. 1991 Jul 9;199(3):371-3. doi: 10.1016/0014-2999(91)90503-i.

Abstract

Six WAG/Rij rats, an animal model of human absence epilepsy, were injected intraperitoneally with riluzole. At 4 mg/kg, riluzole decreased the number, mean duration and spike-frequency of the spontaneously occurring discharges for 3 h. Riluzole also increased slow wave sleep at the expense of waking. As riluzole at 3 mg/kg decreased the number and spike-frequency of the discharges without inducing a sedative effect, this compound could be of therapeutic interest in human absence epilepsy.

MeSH terms

  • Animals
  • Anticonvulsants / pharmacology*
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / physiology
  • Circadian Rhythm / drug effects
  • Disease Models, Animal
  • Electromyography
  • Epilepsy, Absence / drug therapy*
  • Epilepsy, Absence / physiopathology
  • Male
  • Rats
  • Rats, Inbred Strains
  • Riluzole
  • Sleep / drug effects*
  • Sleep / physiology
  • Thiazoles / pharmacology*
  • Wakefulness / drug effects*
  • Wakefulness / physiology

Substances

  • Anticonvulsants
  • Thiazoles
  • Riluzole